Skip to content
akaturk Academic measurement

Article detail · 2021 · article

Predicting the outcome of COVID-19 infection in kidney transplant recipients

Journal BMC Nephrology
ISSN1111-1111
YÖKSİS OpenAlex Open access · gold Top 10%
Year2021
Citations46OpenAlex
Citations43Semantic Scholar · 3 influential
Percentile%91.9
FWCI2.611.00 = world average
Scopus (SJR)Q2
WoS (JCR)Q3

Data source split

  • YÖKSİSYÖKSİS article record
  • YÖKSİS venueBMC Nephrology
  • OpenAlexOpenAlex enrichment (abstract, citations, topics)
  • Semantic Scholarcitation count (not merged with OpenAlex)

Abstract

OpenAlex English

BACKGROUND: We aimed to present the demographic characteristics, clinical presentation, and outcomes of our multicenter cohort of adult KTx recipients with COVID-19. METHODS: We conducted a multicenter, retrospective study using data of patients hospitalized for COVID-19 collected from 34 centers in Turkey. Demographic characteristics, clinical findings, laboratory parameters (hemogram, CRP, AST, ALT, LDH, and ferritin) at admission and follow-up, and treatment strategies were reviewed. Predictors of poor clinical outcomes were analyzed. The primary outcomes were in-hospital mortality and the need for ICU admission. The secondary outcome was composite in-hospital mortality and/or ICU admission. RESULTS: One hundred nine patients (male/female: 63/46, mean age: 48.4 ± 12.4 years) were included in the study. Acute kidney injury (AKI) developed in 46 (42.2%) patients, and 4 (3.7%) of the patients required renal replacement therapy (RRT). A total of 22 (20.2%) patients were admitted in the ICU, and 19 (17.4%) patients required invasive mechanical ventilation. 14 (12.8%) of the patients died. Patients who were admitted in the ICU were significantly older (age over 60 years) (38.1% vs 14.9%, p = 0.016). 23 (21.1%) patients reached to composite outcome and these patients were significantly older (age over 60 years) (39.1% vs. 13.9%; p = 0.004), and had lower serum albumin (3.4 g/dl [2.9-3.8] vs. 3.8 g/dl [3.5-4.1], p = 0.002), higher serum ferritin (679 μg/L [184-2260] vs. 331 μg/L [128-839], p = 0.048), and lower lymphocyte counts (700/μl [460-950] vs. 860 /μl [545-1385], p = 0.018). Multivariable analysis identified presence of ischemic heart disease and initial serum creatinine levels as independent risk factors for mortality, whereas age over 60 years and initial serum creatinine levels were independently associated with ICU admission. On analysis for predicting secondary outcome, age above 60 and initial lymphocyte count were found to be independent variables in multivariable analysis. CONCLUSION: Over the age of 60, ischemic heart disease, lymphopenia, poor graft function were independent risk factors for severe COVID-19 in this patient group. Whereas presence of ischemic heart disease and poor graft function were independently associated with mortality.

Topics

Citations

OpenAlex cited_by_count. Not a WoS or Scopus citation count; those sources have no separate column here.

46citationsOpenAlex · cited_by_count (cache / database)

18 publications in the local catalog that cite this work (OpenAlex reference match; not the full global list).

  1. 2022 Middle-term outcomes in renal transplant recipients with COVID-19: a national, multicenter, controlled studyCitations 5 · OpenAlex
  2. 2022 Middle-term outcomes in renal transplant recipients with COVID-19: a national, multicenter, controlled studyCitations 5 · OpenAlex
  3. 2022 Middle-term outcomes in renal transplant recipients with COVID-19: a national, multicenter, controlled studyCitations 5 · OpenAlex
  4. 2022 Middle-term outcomes in renal transplant recipients with COVID-19: a national, multicenter, controlled studyCitations 5 · OpenAlex
  5. 2022 Middle-term outcomes in renal transplant recipients with COVID-19: a national, multicenter, controlled studyCitations 5 · OpenAlex
  6. 2022 Middle-term outcomes in renal transplant recipients with COVID-19: a national, multicenter, controlled studyCitations 5 · OpenAlex
  7. 2022 Middle-term outcomes in renal transplant recipients with COVID-19: a national, multicenter, controlled studyCitations 5 · OpenAlex
  8. 2022 Middle-term outcomes in renal transplant recipients with COVID-19: a national, multicenter, controlled studyCitations 5 · OpenAlex
  9. 2022 Middle-term outcomes in renal transplant recipients with COVID-19: a national, multicenter, controlled studyCitations 5 · OpenAlex
  10. 2022 Impact of the COVID-19 pandemic on interest in renal diseasesCitations 4 · OpenAlex

Authors

9
  1. ÖZGÜR AKIN OTO 1
  2. SAVAŞ ÖZTÜRK 2
  3. KENAN TURGUTALP 3
  4. MUSTAFA ARICI 4
  5. NADİR ALPAY 5
  6. ÖZGÜR MERHAMETSİZ 6
  7. SAVAŞ SİPAHİ 7
  8. MEHMET EMİN DEMİR ATILIM ÜNİVERSİTESİ 8
  9. MEHMET RIZA ALTIPARMAK İSTANBUL ÜNİVERSİTESİ-CERRAHPAŞA 9